23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function.
Oncoimmunology. 2023 Jun 5;12(1):2217737. doi: 10.1080/2162402X.2023.2217737. eCollection 2023. Oncoimmunology. 2023. PMID: 37288324 Free PMC article.